乳腺增生性病变和乳腺癌中肿瘤坏死因子受体相关蛋白-1(TRAP1)的表达临床意义分析

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:pngegeok
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:探讨TRAP1在乳腺病变恶性转化过程中的可能作用,分析其表达水平与乳腺癌各病理参数间的关系。方法:收集2009-04-15-2012-04-15中国医科大学附属第一医院诊治的低级别导管内癌(低级别DCIS)、高级别导管内癌(高级别DCIS)各15例和浸润性导管癌100例,以乳腺导管普通型增生(UDH)、乳腺不典型增生(ADH)各15例作为对照,应用免疫组织化学法检测上述标本中TRAP1的表达及临床意义。
其他文献
目的:探讨和总结自体纯化脂肪颗粒在小颏患者的临床应用及治疗体会.方法:65例患者,在腹部或者大腿吸脂及脂肪冲洗纯化后,行颏部脂肪充填.进行治疗前后颏部形态对比及术后二次充填比例,评估纯化自体脂肪颗粒充填有效率及患者满意度.结果:65例患者,15例一次性注射,效果满意;35例二次注射,补注后效果满意.15例进行第三次注射.无一例发生感染、血肿、脂肪液化等并发症.结论:纯化自体脂肪颗粒因其来源丰富、不
目的:IASLC/ATS/ERS在201 1年对肺腺癌按照肿瘤的侵袭性进行了重新定义,本研究拟通过总结早期肺腺癌各亚型薄层CT影像学特征,分析ⅠA期肺腺癌中能够预测肿瘤侵袭性的影像学指标。
目的: Squamous cell carcinomas (SCC) account for approximately 30% of non-small cell lung cancer (NSCLC).Current stagingmethods do not adequately predict outcome for this disease.
Objective: Breast cancer (BC) is the most widespread cause of cancer-related death among women.Many published studies have assessed the association between Glutathione S-transferase P1 (GSTP1) rs1695
Objective: Despite advances in basic and clinical research, metastasis remains the leading cause of death in breast cancer patients.Genetic abnormalities in mitochondria, including mutations affecting
Objective: Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is prone to recurrence and metastasis with worse prognosis.
Objective: Diabetic patients with breast cancer receiving metformin and neoadjuvant chemotherapy have a higher pathologic complete response (pCR) rate than do diabetics not receiving metformin, but fi
Objective: Non-alcoholic fatty liver disease (NAFLD) induced by selective estrogen receptor modulators (SERMs) treatment may be related to treatment efficacy for the antagonism of circulating estrogen
Objective: The application of mammography benefits more and more patients by an increased detection of smaller invasive tumors, and it would be helpful if mammography could be used in determining prog
Objective: Tamoxifen resistance leads to lethality in a substantial fraction of estrogen positive breast cancer patients.The aim of the study is to identify the effect of PAK4 on tamoxifen resistance